MBL2 and cancer: Recently, it was found that mannan-binding lectins themselves could demonstrate anticancer activity against animal model of human cancers, such as gastric [15], colon [16], and breast cancers [17], targeting the mannose residues on the cancer cell’s surface and inducing apoptosis and autophagy pathways in the malignant cells [18].